Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Diem

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Journal of Diabetes Science and Technology|May 7, 2026
Automated Insulin Delivery Systems: Impact on Clinical Practice, Discontinuation, Rejection, and Reasons for Not Managing WellTimm Roos, Norbert Hermanns, Lutz Heinemann, et al.
Journal of Diabetes Science and Technology|May 6, 2026
Use of Continuous Glucose Monitoring and Insulin Pump Technologies in People With Type 2 Diabetes: Insights From a Survey of Health Care Professionals and Patients in Germany, Austria, and SwitzerlandMirjam Elisabeth Eiswirth, Michael Resl, Bernhard Kulzer, et al.
Journal of Diabetes Science and Technology|April 11, 2026
<i>Green</i> Diabetes: Already a Decisive Factor for or Against Technology for People Living With Diabetes?Stefanie Hossmann, Aritz Lizoain, Timm Roos, et al.
Journal of Diabetes Science and Technology|May 8, 2026
Diabetes Technology Across the Lifespan of People With Diabetes (Ages 2-88 Years): Insights From the dt-Report on Usage Trends Across all Age GroupsNorbert Hermanns, Dominic Ehrmann, Lutz Heinemann, et al.
Journal of Diabetes Science and Technology|August 21, 2023
Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for ReportingGuido Freckmann, Manuel Eichenlaub, Delia Waldenmaier, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 18, 2025
Clinical assessment and acceptance criteria for continuous glucose monitoring (CGM) system performance: A proposed guideline by the IFCC Working Group on CGMStefan Pleus, Manuel Eichenlaub, Pradeep Kumar Dabla, et al.
BMJ (Clinical Research Ed.)|December 11, 2013
Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR studyLan Shen, Bimal R Shah, Eric M Reyes, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 8, 2018
National public health system responses to diabetes and other important noncommunicable diseases : Background, goals, and results of an international workshop at the Robert Koch InstituteLukas Reitzle, Sylvia Hansen, Rebecca Paprott, et al.
Diabetes Technology & Therapeutics|January 9, 2024
Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring SystemsManuel Eichenlaub, Stefan Pleus, Martina Rothenbühler, et al.
Lancet (London, England)|September 18, 2007
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisChristoph Stettler, Simon Wandel, Sabin Allemann, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Diabetes Science and Technology|May 7, 2026
Automated Insulin Delivery Systems: Impact on Clinical Practice, Discontinuation, Rejection, and Reasons for Not Managing WellTimm Roos, Norbert Hermanns, Lutz Heinemann, et al.
Journal of Diabetes Science and Technology|May 6, 2026
Use of Continuous Glucose Monitoring and Insulin Pump Technologies in People With Type 2 Diabetes: Insights From a Survey of Health Care Professionals and Patients in Germany, Austria, and SwitzerlandMirjam Elisabeth Eiswirth, Michael Resl, Bernhard Kulzer, et al.
Journal of Diabetes Science and Technology|April 11, 2026
<i>Green</i> Diabetes: Already a Decisive Factor for or Against Technology for People Living With Diabetes?Stefanie Hossmann, Aritz Lizoain, Timm Roos, et al.
Journal of Diabetes Science and Technology|May 8, 2026
Diabetes Technology Across the Lifespan of People With Diabetes (Ages 2-88 Years): Insights From the dt-Report on Usage Trends Across all Age GroupsNorbert Hermanns, Dominic Ehrmann, Lutz Heinemann, et al.
Journal of Diabetes Science and Technology|August 21, 2023
Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for ReportingGuido Freckmann, Manuel Eichenlaub, Delia Waldenmaier, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 18, 2025
Clinical assessment and acceptance criteria for continuous glucose monitoring (CGM) system performance: A proposed guideline by the IFCC Working Group on CGMStefan Pleus, Manuel Eichenlaub, Pradeep Kumar Dabla, et al.
BMJ (Clinical Research Ed.)|December 11, 2013
Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR studyLan Shen, Bimal R Shah, Eric M Reyes, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 8, 2018
National public health system responses to diabetes and other important noncommunicable diseases : Background, goals, and results of an international workshop at the Robert Koch InstituteLukas Reitzle, Sylvia Hansen, Rebecca Paprott, et al.
Diabetes Technology & Therapeutics|January 9, 2024
Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring SystemsManuel Eichenlaub, Stefan Pleus, Martina Rothenbühler, et al.
Lancet (London, England)|September 18, 2007
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisChristoph Stettler, Simon Wandel, Sabin Allemann, et al.
Pageof 7